The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Parathyroid Hormone Market At The End Of The 2026–2030 Forecast Period?
The parathyroid hormone market size has shown considerable growth in recent years. Its valuation is set to climb from $2.51 billion in 2025 to $2.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.5%. This historical expansion can be traced to various factors including the constrained availability of recombinant parathyroid hormone, a general lack of disease awareness among patients, the continued reliance on conventional vitamin D therapy, the development of hospital and clinic infrastructure, and an increase in post-surgical parathyroid complications.
The parathyroid hormone market is projected to experience substantial expansion in the coming years, with its size forecast to reach $4.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This anticipated growth during the forecast period is primarily driven by several factors, including the advancement of parathyroid hormone analogues, increased uptake of personalized medicine strategies, the proliferation of hospital and specialty clinics, the incorporation of digital tools for patient monitoring, and intensified government and healthcare efforts addressing hypocalcemia and hypoparathyroidism. Key trends anticipated during this period encompass the increasing prevalence of hypocalcemia and hypoparathyroidism, a rise in the application of recombinant parathyroid hormone therapies, the development of more parathyroid hormone analogues for tailored treatment, the broadening of hospital and clinic-based parathyroid care programs, and a greater emphasis on post-surgical management alongside vitamin D supplementation.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Parathyroid Hormone Market?
The parathyroid hormone market is anticipated to expand due to the rising geriatric population. This demographic, comprising older adults generally 65 years and above, often faces age-related health issues necessitating specialized care and assistance. Such a demographic shift stems from longer life expectancies, medical progress, and decreasing birth rates, leading to a greater elderly segment in society. Parathyroid hormone plays a crucial role for the geriatric population by regulating calcium levels and bone metabolism, thereby aiding in the prevention of osteoporosis and fractures frequently observed in older adults. For example, data from January 2024, published by the US-based nonprofit organization, the Population Reference Bureau, indicates that the number of Americans aged 65 and above is projected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Concurrently, this demographic’s proportion of the total population is also forecasted to increase from 17% to 23% over the identical timeframe. Consequently, the expanding geriatric population is a key factor propelling the parathyroid hormone market’s expansion.
What Segment Types Make Up The Parathyroid Hormone Market?
The parathyroid hormone market covered in this report is segmented –
1) By Disease Type: Hypocalcemia, Hypoparathyroidism
2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues
3) By End-User: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency
2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism
Which Market Trends Are Creating New Opportunities In The Parathyroid Hormone Market?
Leading companies in the parathyroid hormone market are focusing on developing biosimilars of parathyroid-based drugs, such as prodrugs of parathyroid hormone (PTH), to enhance treatment options. A prodrug of parathyroid hormone (PTH) is an inactive compound that transforms into active parathyroid hormone after administration, enabling prolonged release and stable therapeutic outcomes for calcium regulation and bone health. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, announced that the Food & Drug Administration (FDA) approved YORVIPATH (palopegteriparatide) as the first and only treatment for hypoparathyroidism in adults. This once-daily prodrug ensures continuous exposure to PTH, benefiting an estimated 70,000 to 90,000 patients in the United States. Ascendis Pharma, the manufacturer, provides patient support through its ascendis signature access program (A.S.A.P.) program, but users must regularly monitor serum calcium levels for potential hypercalcemia or hypocalcemia.
Who Are The Key Players Driving Competition In The Parathyroid Hormone Market?
Major companies operating in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited
Read the full parathyroid hormone market report here:
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
Which Regions Are Projected To Dominate The Parathyroid Hormone Market In The Coming Years?
North America was the largest region in the parathyroid hormone market in 2025. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Parathyroid Hormone Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3427&type=smp
Browse Through More Reports Similar to the Global Parathyroid Hormone Market 2026, By The Business Research Company
Hormonal Contraceptives Market Report 2026
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Drugs For Hormonal Replacement Therapy Market Report 2026
Thyroid Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model